Related Experiment Video

Updated: Oct 29, 2025

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.7K

Long-term survival in multiresistant metastatic choriocarcinoma after pembrolizumab treatment: A case report

V Paspalj1, S Polterauer1,2, N Poetsch3

  • 1Division of General Gynecology and Gynecologic Oncology, Department of Obstetrics and Gynecology, Gynecologic Cancer Unit, Comprehensive Cancer Center, Medical University of Vienna, Austria.

Gynecologic Oncology Reports
|July 14, 2021
PubMed

Keywords:
CPI, checkpoint inhibitorCT, computed tomographyChoriocarcinomaECOG, Eastern Cooperative Oncology GroupETT, epithelioid trophoblastic tumorGTD, gestational trophoblastic diseaseGTNGTN, gestational trophoblastic neoplasiaPD-1/PDL-1, programmed cell death-1/ programmed cell death ligand-1PSTT, placental site trophoblastic tumorPembrolizumabWHO, Worl Health OrganizationcMRI, cerebral magnetic resonance imagingβ-HCGβ-HCG, beta-human chorionic gonadotropin

More Related Videos

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

5.7K
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

711

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K